CLI-05993AB1-08: BETRI-Prospective: Asthma control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 g]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 g]) (clinicaltrialsregister.eu) - May 28, 2026 - P4 | N=606 | Not yet recruiting | Sponsor: Chiesi Farmaceutici S.p.A.
New P4 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
|